Adults with congenital heart disease and heart transplantation: optimizing outcomes

Sara W Goldberg1, Stacy A Fisher2, Brody Wehman3

  • 1Division of Pediatric Cardiology, Boston Children's Hospital, Boston, Massachusetts.

Insights

Adults with congenital heart disease (ACHD) face unique challenges in heart transplantation. This review examines their complex physiology, high waiting list risks, and elevated post-transplant mortality, suggesting improved listing criteria.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Adult Congenital Heart Disease

Background:

  • The population of adults with congenital heart disease (ACHD) is increasing.
  • ACHD patients present unique challenges for heart transplantation evaluation and management.
  • Existing heart transplant criteria may not adequately address the needs of ACHD patients.

Purpose of the Study:

  • To describe the complex anatomic and physiologic features of ACHD patients undergoing heart transplantation.
  • To discuss factors contributing to prolonged waiting times and adverse outcomes on the waiting list for ACHD patients.
  • To identify risk factors for increased morbidity and mortality after heart transplantation in ACHD patients.

Main Methods:

  • Comprehensive review of existing literature on heart transplantation in ACHD patients.
  • Analysis of patient characteristics, waiting list outcomes, and post-transplant results.
  • Identification of key challenges and risk factors.

Main Results:

  • ACHD patients exhibit complex congenital defects and physiology impacting transplant candidacy.
  • High waiting list times contribute to significant morbidity and mortality in this population.
  • Elevated post-transplant morbidity and mortality rates are observed in ACHD recipients.

Conclusions:

  • Further research is needed to optimize heart transplantation for ACHD patients.
  • Current listing criteria require re-evaluation to better serve the growing ACHD population.
  • Strategies to mitigate risks and improve outcomes for ACHD patients post-transplant are essential.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
821
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
630
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
455
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K